On Invalid Date, Cardiol Therapeutics (NASDAQ: CRDL) reported Q4 2023 earnings per share (EPS) of -$0.09, up 12.5% year over year. Total Cardiol Therapeutics earnings for the quarter were -$5.74 million. In the same quarter last year, Cardiol Therapeutics's earnings per share (EPS) was -$0.08.
As of Q2 2024, Cardiol Therapeutics's earnings has grown year over year. Cardiol Therapeutics's earnings in the past year totalled -$20.68 million.
What is CRDL's earnings date?
Cardiol Therapeutics's earnings date is Invalid Date. Add CRDL to your watchlist to be reminded of CRDL's next earnings announcement.
What was CRDL's revenue last quarter?
On Invalid Date, Cardiol Therapeutics (NASDAQ: CRDL) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Cardiol Therapeutics's revenue was $0.00.
What was CRDL's revenue growth in the past year?
As of Q2 2024, Cardiol Therapeutics's revenue has grown null year over year. Cardiol Therapeutics's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.